MiR-498 regulated FOXO3 expression and inhibited the proliferation of human ovarian cancer cells

Biomedicine and Pharmacotherapy

Volumn 72, Issue , 2015, Pages 52-57

  Liu, Ruonan ^a   Liu, Fenghua ^a   Li, Lei ^a   Sun, Miaomiao ^a   Chen, Kuisheng ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Cell proliferation; FOXO3; Human ovarian cancer; MiR 498

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MICRORNA; MICRORNA 498; TRANSCRIPTION FACTOR FKHRL1; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; FORKHEAD TRANSCRIPTION FACTOR; FOXO3 PROTEIN, HUMAN; MESSENGER RNA; MIRN498 MICRORNA, HUMAN; TUMOR PROTEIN;

3' UNTRANSLATED REGION; ARTICLE; CELL CYCLE S PHASE; CELL PROLIFERATION; COLONY FORMATION; DOWN REGULATION; EPITHELIUM CELL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; MTT ASSAY; OVARIAN CANCER CELL LINE; OVARY CARCINOMA; OVARY CELL; OVARY SURFACE EPITHELIAL CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; WILD TYPE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; RNA, MESSENGER; UP-REGULATION;

EID: 84930510122     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2015.04.005     Document Type: Article

References (22)

1. Siegel R., Ma J., Zou Z., Jemal A. Cancer statistics, 2014. CA Cancer J. Clin. 2014, 64:9-29.
2. Kumar A., Bakkum-Gamez J.N., Weaver A.L., McGree M.E., Cliby W.A. Impact of obesity on surgical and oncologic outcomes in ovarian cancer. Gynecol. Oncol. 2014, 135:19-24.
3. Di Leva G., Garofalo M., Croce C.M. MicroRNAs in cancer. Annu. Rev. Pathol. 2014, 9:287-314.
4. Shoshan E., Mobley A.K., Braeuer R.R., Kamiya T., Huang L., Vasquez M.E., Salameh A., Lee H.J., Kim S.J., Ivan C., Velazquez-Torres G., Nip K.M., Zhu K., Brooks D., Jones S.J., Birol I., Mosqueda M., Wen Y.Y., Eterovic A.K., Sood A.K., Hwu P., Gershenwald J.E., Gordon Robertson A., Calin G.A., Markel G., Fidler I.J., Bar-Eli M. Reduced adenosine-to-inosine mir-455-5p editing promotes melanoma growth and metastasis. Nat. Cell Biol. 2015, 17:311-321.
5. Wan X., Ding X., Chen S., Song H., Jiang H., Fang Y., Li P., Guo J. The functional sites of miRNAs and lncRNAs in gastric carcinogenesis. Tumour Biol. 2015, 36:521-532.
6. Chan S.H., Wang L.H. Regulation of cancer metastasis by microRNAs. J. Biomed. Sci. 2015, 22:9.
7. Gopalan V., Smith R.A., Lam A.K. Downregulation of microRNA-498 in colorectal cancers and its cellular effects. Exp. Cell Res. 2015, 330:423-428.
8. Kasiappan R., Shen Z., Tse A.K., Jinwal U., Tang J., Lungchukiet P., Sun Y., Kruk P., Nicosia S.V., Zhang X., Bai W. 1,25-Dihydroxyvitamin d3 suppresses telomerase expression and human cancer growth through microRNA-498. J. Biol. Chem. 2012, 287:41297-41309.
9. Leivonen S.K., Sahlberg K.K., Makela R., Due E.U., Kallioniemi O., Borresen-Dale A.L., Perala M. High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth. Mol. Oncol. 2014, 8:93-104.
10. Santarpia L., Calin G.A., Adam L., Ye L., Fusco A., Giunti S., Thaller C., Paladini L., Zhang X., Jimenez C., Trimarchi F., El-Naggar A.K., Gagel R.F. A miRNA signature associated with human metastatic medullary thyroid carcinoma. Endocrine-Relat. Cancer 2013, 20:809-823.
11. Lin C., Wu Z., Lin X., Yu C., Shi T., Zeng Y., Wang X., Li J., Song L. Knockdown of FLOT1 impairs cell proliferation and tumorigenicity in breast cancer through upregulation of FOXO3a. Clin. Cancer Res. 2011, 17:3089-3099.
12. Cappellini A., Tabellini G., Zweyer M., Bortul R., Tazzari P.L., Billi A.M., Fala F., Cocco L., Martelli A.M. The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin d1 expression. Leukemia 2003, 17:2157-2167.
13. Kinose Y., Sawada K., Nakamura K., Kimura T. The role of microRNAs in ovarian cancer. BioMed Res. Int. 2014, 2014:249393.
14. Li S.D., Zhang J.R., Wang Y.Q., Wan X.P. The role of microRNAs in ovarian cancer initiation and progression. J. Cell. Mol. Med. 2010, 14:2240-2249.
15. Mezzanzanica D., Bagnoli M., De Cecco L., Valeri B., Canevari S. Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications. Int. J. Biochem. Cell Biol. 2010, 42:1262-1272.
16. Di Leva G., Croce C.M. The role of microRNAs in the tumorigenesis of ovarian cancer. Front. Oncol. 2013, 3:153.
17. Zhao X., Liu Y., Du L., He L., Ni B., Hu J., Zhu D., Chen Q. Threonine 32 (Thr32) of FOXO3 is critical for TGF-beta-induced apoptosis via Bim in hepatocarcinoma cells. Protein Cell 2015, 6:127-138.
18. Li J., Li P., Chen T., Gao G., Chen X., Du Y., Zhang R., Yang R., Zhao W., Dun S., Gao F., Zhang G. Expression of microRNA-96 and its potential functions by targeting FOXO3 in non-small cell lung cancer. Tumour Biol. 2015, 36:685-692.
19. Jin Z., Zheng L., Xin X., Li Y., Hua T., Wu T., Wang H. Upregulation of forkhead box o3 transcription is involved in c2-ceramide induced apoptosis and autophagy in ovarian cancer cells in vitro. Mol. Med. Rep. 2014, 10:3099-3105.
20. Lu M., Zhao Y., Xu F., Wang Y., Xiang J., Chen D. The expression and prognosis of FOXO3a and skp2 in human ovarian cancer. Med. Oncol. (Northwood, London, Engl.) 2012, 29:3409-3415.
21. Xie C., Song L.B., Wu J.H., Li J., Yun J.P., Lai J.M., Xie D.Y., Lin B.L., Yuan Y.F., Li M., Gao Z.L. Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a. PLoS ONE 2012, 7:e40607.
22. Schmidt M., Fernandez de Mattos S., van der Horst A., Klompmaker R., Kops G.J., Lam E.W., Burgering B.M., Medema R.H. Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. Mol. Cell. Biol. 2002, 22:7842-7852.